As only a glycolytic-related gene, DEPDC1 can regulate the malignant progression of oral squamous cell carcinoma through the WNT/β-Catenin pathway, and as one of the prognostic risk predictors of hepatocellular carcinoma [10, 11]. This evidence concerns the gene DEPDC1 and hepatocellular carcinoma.